Waystar Holding Corp. Common Stock
Q1 2026 Earnings
Market Reaction
S&P 500 over the same 30 days: +5.69%.
Did WAY Beat Earnings? Q1 2026 Results
Waystar posted a clean beat across both top and bottom lines in the first quarter of fiscal 2026, with revenue climbing 22.4% year-over-year to $313.87 million against a consensus estimate of $311.68 million, while non-GAAP diluted EPS of $0.42 cleared the $0.39 analyst estimate by 8.70%. The standout driver behind the quarter was a sharp acceleration in subscription revenue, which grew 38% year-over-year to $172.20 million, reflecting continued platform adoption and progress integrating the Iodine acquisition into Waystar's core offering. Adjusted EBITDA reached $135.40 million, with margins expanding to 43.1% from 42.0% a year ago, even as R&D spending rose 66% year-over-year. The company's net revenue retention rate of 111% and a 15% increase in high-value clients underscored the depth of customer engagement. Despite a sector-wide pullback that weighed on health technology stocks broadly, Waystar reaffirmed full-year 2026 guidance calling for revenue of $1.27 billion to $1.29 billion and diluted non-GAAP EPS of $1.59 to $1.68.
- 22% year-over-year revenue growth driven by strong execution and platform expansion
- Subscription revenue grew 38% YoY, reflecting shift toward recurring revenue
- Net revenue retention rate of 111%
- 1,433 clients with over $100,000 in LTM revenue, up 15% YoY
- Adjusted EBITDA margin expanded to 43.1% from 42.0%
- Bookings exceeded internal expectations
“Waystar delivered a solid first quarter, driven by strong execution and continued expansion across our platform.”
Waystar CEO, on the earnings call
Forward Guidance & Outlook
For full fiscal year 2026, Waystar expects total revenue between $1.274 billion and $1.294 billion, adjusted EBITDA between $530 million and $540 million, non-GAAP net income between $317 million and $335 million, and diluted non-GAAP net income per share between $1.59 and $1.68.
WAY YoY Financials
WAY Revenue by Segment
Figures from SEC filings and company reports. Not investment advice.